文献速递头颈外科

腮腺肿瘤患者放疗诱导三叉神经毒性的剂量学研究

Dosimetric investigation of radiation-induced trigeminal nerve toxicity in parotid tumor patients.
PubMed 文献 · Head Neck · 2023-09-22

这项回顾性剂量学研究纳入2013至2018年接受辅助常规分割放疗的18例腮腺肿瘤患者,分析三叉神经剂量与毒性的关联并确定毒性阈值。中位随访29.5个月,61%患者出现1-2级晚期三叉神经毒性;总放疗剂量、Dmax、PTV-TN Dmax、D1cc、D0.5cc、D0.1cc均对三叉神经毒性有显著影响,Dmax、PTV-TN Dmax、D0.1cc、D0.5cc、D1cc的毒性阈值分别为66、65.5、65.25、63.6、62.7 Gy。作者认为当前放疗剂量下毒性发生率较高,值得在前瞻性临床试验中进一步研究放疗诱导的三叉神经损伤。

要点

  • 18例腮腺肿瘤辅助放疗患者中,61%出现1-2级晚期三叉神经毒性。
  • 总放疗剂量、Dmax、PTV-TN Dmax、D1cc、D0.5cc、D0.1cc均对三叉神经毒性有显著影响。
  • Dmax、PTV-TN Dmax、D0.1cc、D0.5cc、D1cc的毒性阈值分别为66、65.5、65.25、63.6、62.7 Gy。

核心结论

  • 作者认为,基于这项回顾性剂量学研究,腮腺肿瘤患者在当前放疗剂量下三叉神经毒性发生率较高,放疗诱导的三叉神经损伤值得在前瞻性临床试验中进一步研究。

研究设计与样本

  • 回顾性研究,纳入2013年至2018年接受辅助常规分割放疗的18例腮腺肿瘤患者。
  • 在计划CT扫描上勾画三叉神经及其分支,基于剂量体积直方图获取三叉神经受照剂量。
  • 在总处方剂量范围内分析剂量与毒性的关系,放疗相关毒性按不良事件通用术语标准V4.0(CTCAEv4.0)分级。

主要发现

  • 中位随访29.5个月,放疗后61%患者出现1-2级晚期三叉神经毒性,其中1级4例(22%)、2级7例(39%)。
  • 三叉神经损伤症状包括颏部感觉丧失3例、下颌运动困难3例、感觉异常5例。
  • 总放疗剂量(p=0.001)、Dmax(p=0.001)、PTV-TN Dmax(p=0.001)、D1cc(p=0.004)、D0.5cc(p=0.001)、D0.1cc(p=0.01)对三叉神经毒性有显著影响。

关键数值与推荐

  • 导致毒性的截止值:Dmax为66 Gy,PTV-TN Dmax为65.5 Gy,D0.1cc为65.25 Gy,D0.5cc为63.6 Gy,D1cc为62.7 Gy。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We aimed to describe the association between trigeminal nerve (TN) dose and toxicity and determine a threshold value that leads to TN toxicity in patients with parotid tumors treated with adjuvant conventional fractionated radiation therapy. METHODS AND MATERIALS: Eighteen patients who underwent adjuvant radiotherapy (RT) between 2013 and 2018 were included in this retrospective study. TN and its branches were outlined subsequently on the planning CT scans. The doses received by TN were obtained based on the dose-volume histogram. The dose and toxicity relationship was investigated over the total prescribed dose. RT-related toxicity was graded according to Common Terminology Criteria for Adverse Events V4.0 (CTCAEv4.0). RESULTS: The median follow-up was 29.5 months. After RT, 61% of patients had Grade I-II late TN toxicity divided into Grade I in 4 (22%) and Grade II in 7 (39%) patients. TN injury symptoms were as follows: loss of sensation in the chin area in 3, difficulty in jaw movements in 3, and paresthesia in 5 patients. The total RT dose (p = 0.001), Dmax (p = 0.001), PTV-TN Dmax (p = 0.001), D1cc (p = 0.004), D0.5cc (p = 0.001), and D0.1cc (p = 0.01) had a significant effect on TN toxicity. Cut-off values leading to toxicity were determined as 66, 65.5, 65.25, 63.6, and 62.7 Gy for Dmax, PTV-TN Dmax, D0.1cc, D 0.5cc, and D1cc, respectively. CONCLUSIONS: Radiation-induced TN injury in head and neck cancer patients may further be investigated in clinically prospective trials by virtue of high toxicity rates with current RT doses in our retrospectively designed dosimetric study in parotid tumors.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Duru Birgi S, Akyurek S, Birgi E, et al. Dosimetric investigation of radiation-induced trigeminal nerve toxicity in parotid tumor patients. Head Neck. 2023. PMID: 37740459. doi:10.1002/hed.27524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。